Released: May 24, 2016
Defense Health Program
Department of Defense Epilepsy Research Program
Funding Opportunities for Fiscal Year 2016
The Fiscal Year 2016 (FY16) Defense Appropriations Act provides $7.5 million (M) to the Department of Defense Epilepsy Research Program (ERP). The ERP supports research that will explore the causative links between TBI and epilepsy, with the hope that one day post-traumatic epilepsy will be preventable. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, Research, Development, and Acquisition (DHA RDA) Directorate manages and executes the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP).
The ERP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. The FY16 ERP Program Announcement and General Application Instructions for the following award mechanism are anticipated to be posted on the Grants.gov website in July 2016. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
FY16 ERP Focus Areas:
All applications for the FY16 ERP funding opportunities must address at least one of the following FY16 Focus Areas. An application that proposes research outside of these FY16 Focus Areas is acceptable, as long as the applicant provides a strong rationale as to the relevance of the research to the ERP's mission.
The ERP FY16 Focus Areas are as follows:
ERP FY16 Focus Areas
Epidemiology: Epidemiological characterization of post traumatic epilepsy (PTE) following TBI, which may include:
Markers and Mechanisms: Identifying markers or mechanisms (via clinical or preclinical models) that address PTE:
Models of PTE: Development of new models or better characterization of existing etiologically relevant models for PTE, including repetitive TBI.
Psychogenic Non-Epileptic Seizures: Exploration of the epidemiology, mechanisms, risk factors, or markers of PNES subsequent to TBI. Research on non-pharmacological interventions in this population is also encouraged.
Applications addressing persistence and direct detection of Lyme borreliae are highly encouraged.
|Award Mechanism||Eligibility||Key Mechanism Elements||Funding|
|Idea Development Award||For either Level I or II, the PI must be an independent investigator at or above the level of Assistant Professor (or equivalent).||
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from Grants.gov. A listing of all CDMRP funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
Applications must be submitted through the federal government's single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, go to the CDMRP website (https://cdmrp.army.mil) and select Subscribe to Funding Opportunities & Program Communications. For more information about other CDMRP administered programs, please visit the CDMRP website (https://cdmrp.army.mil).
Point of Contact:
CDMRP Public Affairs
Last updated Tuesday, January 4, 2022